Salvinorin A. Is it possible to have a truly powerful painkiller that is not addictive?
May 7, 2018
We need new drugs. The opioid epidemic gripping the United States has brought into public awareness a problem that has bedeviled the world of medical science for decades: is it possible to have a truly powerful painkiller that is not addictive?
Manny Pacquiao and Rodrigo Duterte support the death penalty for drug crimes
July 19, 2016
Pacquiao’s drive to reinstate capital punishment for drug crimes is in line with President Duterte: “If you know of any addicts, go ahead and kill them yourself, as getting their parents to do it would be too painful.”
Activists Bring 51-Foot Cannabis Joint to Hillary Clinton
August 19, 2016
I had the very strange joy of driving a Hillary Clinton rally with a van full of cannabis activists.
Ohio City Gov’t: We have to fine and jail overdose survivors to give them “treatment opportunities”
April 13, 2017
If someone overdoses from heroin or opiate drugs and has to be revived by paramedics or police with naloxone, they will be charged with “inducing panic.”
We Refuse to Endorse Daniel Pinchbeck as a Credible Voice in the Psychedelic Movement
December 5, 2019
Pinchbeck has not publicly engaged in the difficult work of reorganizing his relationship to power, which is a precondition for learning to wield power and authority responsibly. Instead, he has shown that he is predominantly concerned with reestablishing his career and with recentering himself as an authority figure
ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0”
September 27, 2020
Through EmpathBio, ATAI Life Sciences says it will develop “safer” MDMA derivatives for patients with PTSD and calls the Multidisciplinary Association for Psychedelic Studies' (MAPS) approach "MDMA 1.0." MAPS' executive director, Rick Doblin, says that if that's the case, ATAI is "MDMA 0.5."
Why are so many extractive industry executives speculating on psychedelics?
November 3, 2020
Extractive industry is highly speculative by nature and firms are risk tolerant—they either “strike gold” or they don’t. When their gambles fail, psychedelic startups can take over their corporate shells to quickly go public with minimal regulatory scrutiny.
Christopher Valore (AKA The Architect) talks “Conductor,” His Virtual-Reality, Psychedelic-Visual Sandbox Platform
December 7, 2020
Christopher Valore discusses his love of virtual reality; the early days of his company, Club Transcendia; and development of his first official release, “Conductor.”
Hey Psychedelic Science Community, We Need to Talk About Consent
November 13, 2018
Consent is really pretty simple but also apparently complicated, due to our inheritance of a messed up culture.
Psychedelics Can’t be Tested Using Conventional Clinical Trials
May 23, 2017
Should these drugs become part of medicine cabinets from San Francisco to America’s heartland, it will be high time to develop drug tests that control for the cultural diversity of this country’s doctors and patients.